Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ZonePerfect sues Hershey

This article was originally published in The Tan Sheet

Executive Summary

The Abbott Labs subsidiary filed suit against the food and confectionary firm and "Zone" diet guru Barry Sears, PhD, for trademark infringement in Massachusetts district court. The suit alleges that Hershey's SmartZone nutrition bar - scheduled for launch in the third quarter - infringes on Abbott's marks for ZonePerfect products and "is likely to cause significant and irreparable consumer confusion regarding ZonePerfect's ZONE marks." Abbott acquired the brand in July 2003 (1"The Tan Sheet" July 28, 2003, p. 8)...

You may also be interested in...



Abbott’s Acquisition Of ZonePerfect Complements Medical Nutrition Business

Abbott Laboratories' Ross Products division will enter the rapidly growing sports/healthy living nutritional bar market segment through its acquisition of ZonePerfect Nutrition

Akorn Defaults On Loan Agreement After Sale Bid Falls Flat

Facing soaring legal costs stemming from its failed merger with Fresenius Kabi and burdened by substantial debt, Akorn elected to put itself up for sale earlier this year in order to help repay lenders. But the company has now defaulted on an agreement with its creditors after no bidder stepped up to the plate.

Pipeline Watch: Vericiguat, Evinacumab Phase III Readouts

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Topics

UsernamePublicRestriction

Register

PS096730

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel